Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer

BACKGROUND: ‘Flare phenomenon’ after initial luteinizing hormone-releasing hormone agonist administration is a widely approved concept in the treatment of prostate cancer. In most guidelines, concomitant therapy with anti-androgens is recommended to prevent this flare phenomenon. However, there are...

Descripción completa

Detalles Bibliográficos
Autores principales: Uehara, Sho, Yuasa, Takeshi, Fujii, Yasuhisa, Yano, Akihiro, Yamamoto, Shinya, Masuda, Hitoshi, Fukui, Iwao, Yonese, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526290/
https://www.ncbi.nlm.nih.gov/pubmed/26242866
http://dx.doi.org/10.1186/s13104-015-1297-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526290/
https://www.ncbi.nlm.nih.gov/pubmed/26242866
http://dx.doi.org/10.1186/s13104-015-1297-3

Ejemplares similares